Dietary zinc deficiency promotes Acinetobacter baumannii lung infection via IL-13 in mice

Area of Science:

• Microbiology
• Immunology
• Nutritional Science

Background:

• Dietary zinc deficiency is a significant risk factor for pneumonia.
• Acinetobacter baumannii, a multidrug-resistant bacterium, is a primary cause of ventilator-associated pneumonia.
• Patients at risk for A. baumannii pneumonia often experience zinc deficiency.

Purpose of the Study:

• To investigate the role of host zinc deficiency in the pathogenesis of Acinetobacter baumannii pneumonia.
• To determine if zinc deficiency exacerbates A. baumannii infection in a mouse model.

Main Methods:

• Establishment of a mouse model with dietary zinc deficiency and acute A. baumannii pneumonia.
• Quantification of bacterial burdens in lungs and spleen.
• Measurement of pro-inflammatory cytokine levels, specifically IL-13.
• Assessment of the effects of IL-13 administration and anti-IL-13 antibody neutralization.

Main Results:

• Zinc-deficient mice exhibited significantly higher A. baumannii lung burdens, increased dissemination to the spleen, and elevated mortality rates.
• Infection led to increased production of pro-inflammatory cytokines, including IL-13, in zinc-deficient mice.
• IL-13 administration enhanced bacterial dissemination in zinc-sufficient mice.
• Neutralization of IL-13 protected zinc-deficient mice against bacterial dissemination and mortality.

Conclusions:

• Host zinc deficiency contributes to the pathogenesis of Acinetobacter baumannii pneumonia.
• Interleukin-13 plays a critical role in mediating A. baumannii dissemination and mortality in zinc-deficient hosts.
• Anti-IL-13 antibody therapy presents a potential therapeutic strategy for treating A. baumannii pneumonia, particularly in zinc-deficient individuals.